Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2021 ∙ Kheyrandish, S. Rastgar, A. Arab-Zozani, M. Sarab, G. A.

Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies

  • Children
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Sabeena, S. Ravishankar, N.

Postvaccination prevalence of vaccine-Human Papillomavirus (vHPV) genotypes among the target population: A systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Barenbrug, L. Groen, M. T. Hoentjen, F. van Drongelen, J. Reek, J. M. P. A. V. D. Joosten, I. de Jong, E. M. G. J. van der Molen, R. G.

Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis

  • Newborn
  • Pregnant women
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Suarez-Lledo, V. Alvarez-Galvez, J.

Prevalence of health misinformation on social media: Systematic review

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Veronese, N. Saccaro, C. Demurtas, J. Smith, L. Dominguez, L. J. Maggi, S. Barbagallo, M.

Prevalence of unwillingness and uncertainty to vaccinate against COVID-19 in older people: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Omatola, C. A. Ogunsakin, R. E. Olaniran, A. O.

Prevalence, Pattern and Genetic Diversity of Rotaviruses among Children under 5 Years of Age with Acute Gastroenteritis in South Africa: A Systematic Review and Meta-Analysis

  • Africa
  • South Africa
  • Newborn
  • Children
  • Rotavirus
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Yuasa, A. Yonemoto, N. LoPresti, M. Ikeda, S.

Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review

  • All age groups
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Kow, C. S. Hasan, S. S.

Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Becerra-Culqui, T. A. Sy, L. S. Solano, Z. Tseng, H. F.

Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review

  • Americas
  • United States of America
  • All age groups
  • Pregnant women
  • Meningococcal disease
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Santosa, A. Xu, C. Arkachaisri, T. Kong, K. O. Lateef, A. Lee, T. H. Leong, K. H. Low, A. H. L. Sriranganathan, M. K. Tan, T. C. Teng, G. G. Thong, B. Y. Fong, W. Lahiri, M.

Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...